Close Menu

NEW YORK (GenomeWeb) – Signature Science said yesterday that it has been awarded a contract from the US Centers for Disease Control and Prevention to evaluate and develop molecular tools to detect and follow the spread of specific bacteria and microbial communities in healthcare settings.

Brian Schimmoller, vice president at Austin, Texas-based Signature Science, noted in an email that the 12-month contract has a value of approximately $560,000.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.